Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in …

K Kurose, E Sugiyama, Y Saito - Drug metabolism and …, 2012 - jstage.jst.go.jp
Drug lag, recently discussed extensively in Japan, can be divided into two phases: clinical
development time and application review time. The former factor is still an important problem …

[PDF][PDF] Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism

E Sugiyama, N Kaniwa, SR Kim… - Journal of Clinical …, 2007 - researchgate.net
Purpose Gemcitabine is rapidly metabolized to its inactive metabolite, 2, 2-difluorodeoxyuridine
(dFdU), by cytidine deaminase (CDA). We previously reported that a patient with …

[HTML][HTML] Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement

…, Y Saito, H Sawai, H Miyadera, E Sugiyama… - Scientific reports, 2014 - nature.com
Stevens-Johnson syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN),
are acute inflammatory vesiculobullous reactions of the skin and mucous membranes. Cold …

Specific HLA types are associated with antiepileptic drug-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese subjects

N Kaniwa, E Sugiyama, Y Saito, K Kurose… - …, 2013 - Future Medicine
Aim: This preliminary study investigated genomic biomarkers for Stevens–Johnson syndrome
(SJS) and toxic epidermal necrolysis (TEN), related to three antiepileptic drugs, zonisamide…

IKZF1, a new susceptibility gene for cold medicine–related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement

…, S Basu, T Ozeki, T Mushiroda, E Sugiyama… - Journal of Allergy and …, 2015 - Elsevier
Background Stevens-Johnson syndrome (SJS) and its severe form, toxic epidermal
necrolysis (TEN), are acute inflammatory vesiculobullous reactions of the skin and mucous …

Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the Cytidine Deaminase Gene in a Japanese Cancer Patient Treated with Gemcitabine …

…, N Saijo, T Yoshida, H Ishii, J Furuse, E Sugiyama… - Clinical cancer …, 2005 - AACR
Purpose: We investigated single-nucleotide polymorphisms of the cytidine deaminase gene
(CDA), which encodes an enzyme that metabolizes gemcitabine, to clarify the relationship …

Substrate-dependent functional alterations of seven CYP2C9 variants found in Japanese subjects

K Maekawa, N Harakawa, E Sugiyama, M Tohkin… - Drug metabolism and …, 2009 - ASPET
CYP2C9 is a polymorphic enzyme that metabolizes a number of clinically important drugs.
In this study, catalytic activities of seven alleles found in Japanese individuals, CYP2C9*3 (…

Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms

E Sugiyama, N Kaniwa, SR Kim, R Hasegawa… - Clinical …, 2010 - Springer
Background and Objective Gemcitabine (2′,2’-difluorodeoxycytidine) is an anticancer drug,
which is effective against solid tumours, including non-small-cell lung cancer and …

Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B* 58: 01: a partially predictive but useful biomarker for …

…, J Nishikawa, N Kaniwa, E Sugiyama… - Drug metabolism and …, 2012 - Elsevier
Allopurinol-induced Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) is
strongly associated with HLA-B*58:01 in various populations including Japanese. We …

[HTML][HTML] Survival prediction for pancreatic cancer patients receiving gemcitabine treatment

…, T Okusaka, J Furuse, K Furuta, E Sugiyama… - Molecular & Cellular …, 2010 - ASBMB
Although gemcitabine monotherapy is the standard treatment for advanced pancreatic cancer,
patient outcome varies significantly, and a considerable number do not benefit adequately…